Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment responseAlexander Haragan(University of Liverpool), John R. Gosney(University of Liverpool)Lung CancerJune 5, 201910.1016/j.lungcan.2019.06.005Cited by 171SaveCiteExport RISWatch citationsRelated PapersAccelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry|Laboratory Investigation|2020|30